Gene · 5214
Papers1,761
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,761
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of Autophagy and Metabolism in Hepatocellular Carcinoma: Involvement of Wnt-β-Catenin Pathway. | J Cell Mol Med | 2026 | 41772397 | PubTator, text mining | PubMed |
| Identification and validation of prognostic genes related to glycolysis and M2 macrophage in hepatocellular carcinoma: an integrated analysis of bulk RNA sequencing and single-cell RNA sequencing. | Front Immunol | 2026 | 41766871 | PubTator, text mining | PubMed |
| Azole-Flavonoid Hybrids as Emerging Anticancer Agents: A Bioactivity-Focused Review. | Pharmaceuticals (Basel) | 2026 | 41754878 | PubTator, text mining | PubMed |
| When Estrogen Signaling Refuses to Die: Receptor Rewiring, Compartmentalization, and Endocrine Plasticity in Gynecological Cancers. | Int J Mol Sci | 2026 | 41752059 | PubTator, text mining | PubMed |
| Association Between Catenin Beta-1 (CTNNB1) Gene Polymorphisms and Non-Traumatic Osteonecrosis of the Femoral Head (ONFH). | Curr Issues Mol Biol | 2026 | 41751426 | PubTator, text mining | PubMed |
| The Stiff Side of Cancer: How Matrix Mechanics Rewrites Non-Coding RNA Expression Programs. | Noncoding RNA | 2026 | 41745140 | PubTator, text mining | PubMed |
| Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer. | Curr Oncol | 2026 | 41744893 | PubTator, text mining | PubMed |
| Extracellular vesicles in rheumatoid arthritis: emerging roles in progression, diagnosis, and therapeutic development. | Front Immunol | 2026 | 41743711 | PubTator, text mining | PubMed |
| Fitness Training for γδ T cells in mouse and human atherosclerosis takes place in plaques and artery tertiary lymphoid organs. | Genome Med | 2026 | 41736145 | PubTator, text mining | PubMed |
| PFKM governs metabolic shifts throughout skeletal muscle differentiation. | Nat Metab | 2026 | 41735679 | PubTator, text mining | PubMed |
| Glycolysis-related genes for bladder cancer: A Mendelian randomization analysis. | Biochem Biophys Rep | 2026 | 41732417 | PubTator, text mining | PubMed |
| PFKP binding AMOTL1 promotes tumor aerobic glycolysis and epithelial-mesenchymal transition by modulating Hippo pathway in head and neck cancer. | J Transl Int Med | 2026 | 41727965 | PubTator, text mining | PubMed |
| Single-cell transcriptomics revealed molecular vulnerability in a human midbrain-like organoid model of Parkinson's disease. | iScience | 2026 | 41727181 | PubTator, text mining | PubMed |
| Targeting Metabolic Vulnerabilities in Glioblastoma: a Framework for Multi-node Combination Therapy. | Curr Oncol Rep | 2026 | 41718834 | PubTator, text mining | PubMed |
| Lactylation in colorectal cancer: Unveiling novel mechanisms in metabolism, progression and therapeutic targeting. | Clin Transl Med | 2026 | 41711048 | PubTator, text mining | PubMed |
| Macrophage Hypoxia Signaling Pathways and Their Roles in Sepsis. | J Inflamm Res | 2026 | 41709969 | PubTator, text mining | PubMed |
| Glycolysis enzymes and cellular lactylation in tumour. | Clin Transl Med | 2026 | 41705280 | PubTator, text mining | PubMed |
| β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939. | Technol Cancer Res Treat | 2026 | 41700965 | PubTator, text mining | PubMed |
| The moonlighting functions of glycolytic enzymes in tumorigenesis. | Cell Oncol (Dordr) | 2026 | 41627634 | PubTator, text mining | PubMed |
| SIAH2-WNK1 Signaling Drives Glycolytic Metabolism and Therapeutic Resistance in Colorectal Cancer. | Int J Mol Sci | 2026 | 41596707 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5214/papers?page=3